Internal Medicine, Hematology & Oncology · Dallas, TX
NPI
1366404584
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
5323 Harry Hines Blvd
Dallas, TX, 75390
Phone (214) 648-7070
Groups this clinician bills Medicare through
Medicare paid, 2024
$44K
585 services
Medicare patients, 2024
279
Average age 74
Drug cost, 2024
$3.5M
2,000 prescriptions
Company payments, 2025
$40.88
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dawn L Klemow was code 99214 (office e&m - established), 263 times for 180 patients. In total Dawn L Klemow billed 585 services in 10 codes, and Medicare paid $44K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-05-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 263 | 180 | $73.20 | $19K |
| 99214 Office E&M - Established | Office | 126 | 102 | $59.05 | $7,440 |
| 99215 Office E&M - Established | Facility | 56 | 39 | $107.75 | $6,034 |
| 99213 Office E&M - Established | Office | 36 | 33 | $58.59 | $2,109 |
| 99205 Office E&M - New | Facility | 31 | 31 | $138.19 | $4,284 |
| 99213 Office E&M - Established | Facility | 29 | 28 | $47.26 | $1,370 |
| 99215 Office E&M - Established | Office | 14 | 11 | $104.96 | $1,469 |
By year: 2022 $83K for 920 services; 2023 $37K for 530 services; 2024 $44K for 585 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dawn L Klemow prescribed most often to Medicare patients was Letrozole, with 552 prescriptions and refills. In total Dawn L Klemow wrote 2,000 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 552 | 1,217 | 156 | $11K |
| Anastrozole Generic | 272 | 612 | 70 | $3,810 |
| Tamoxifen Citrate Generic | 124 | 301 | 34 | $3,364 |
| Verzenio Abemaciclib | 88 | 88 | 12 | $1.2M |
| Prochlorperazine Maleate Generic | 56 | 56 | 30 | $428 |
| Potassium Chloride Generic | 54 | 106 | 29 | $703 |
| Kisqali Ribociclib Succinate | 52 | 57 | Under 11 | $885K |
| Exemestane Generic | 50 | 90 | 14 | $4,140 |
| Gabapentin Generic | 47 | 62 | 16 | $394 |
| Trazodone Hcl Generic | 41 | 55 | Under 11 | $179 |
| Ondansetron Hcl Generic | 41 | 41 | 24 | $391 |
| Ibrance Palbociclib | 40 | 40 | Under 11 | $657K |
| Famotidine Generic | 38 | 50 | Under 11 | $346 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 37 | 91 | 12 | $908 |
| Eliquis Apixaban | 34 | 50 | Under 11 | $29K |
Brand drugs: - claims; generic drugs: 1,727 claims; opioid claims: 38.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dawn L Klemow $40.88 ($40.88 in general payments such as food, travel and fees) from 2 companies. The largest payer was Daiichi Sankyo Inc. with $26.23.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.